These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7683585)

  • 41. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF.
    Meldgaard Knudsen L; Jensen L; Gaarsdal E; Nikolaisen K; Johnsen HE
    Bone Marrow Transplant; 2000 Oct; 26(7):717-22. PubMed ID: 11042651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and blood leukocyte dynamics following intranasal administration in rabbits.
    Watanabe Y; Matsumoto Y; Yamaguchi M; Kikuchi R; Takayama K; Nomura H; Maruyama K; Matsumoto M
    Biol Pharm Bull; 1993 Jan; 16(1):93-5. PubMed ID: 7690293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
    Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
    J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J; Moraleda JM; Ortuño F; Lozano ML; Ayala F; Vallejo C; de Arriba F; Vicente V
    Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on cytotoxicity of PSK-induced peritoneal polymorphonuclear leukocytes (PMNs).
    Kato H; Inoue M; Yamamura Y; Kawahito Y; Mukai S; Sugino S; Kondo M
    Biotherapy; 1992; 5(3):177-86. PubMed ID: 1384634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combination effects between KW-2228 and antibiotics against systemic infections in normal and neutropenic mice].
    Sato K; Yoneyama H; Yoshino T
    Jpn J Antibiot; 1992 Jan; 45(1):91-7. PubMed ID: 1379652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases.
    Daifuku R; Andresen J; Morstyn G
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():91-7. PubMed ID: 7691789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of recombinant human granulocyte colony-stimulating factor on granulopoiesis in mice recovering from cyclophosphamide treatment.
    Barrios L; Poletti OH; Agustini MI
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):275-80. PubMed ID: 11031727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant human granulocyte colony-stimulating factor augments cytotoxicity of OK-432-induced polymorphonuclear leukocytes.
    Inoue M; Kato H; Mukai S; Kawahito Y; Asai K; Kimura S; Yamamura Y; Sano H; Sugino S; Kondo M
    Int J Immunopharmacol; 1994 Jan; 16(1):19-28. PubMed ID: 7512080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice.
    Hebert JC; O'Reilly M; Gamelli RL
    Arch Surg; 1990 Aug; 125(8):1075-8. PubMed ID: 1696096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
    Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) against various microbial infections in neutropenic mice.
    Matsumoto M; Matsubara S; Matsuno T; Ono M; Yokota T
    Microbiol Immunol; 1990; 34(9):765-73. PubMed ID: 1704477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H
    Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
    Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
    J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
    Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.